Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROSAIC-DS (PROState AI in Cancer - Decision Support): Evaluation of the Deontics AI Platform for Evidence-based Treatment Planning in Multidisciplinary Cancer Care: Increasing Compliance and Streamlining MDTs in Prostate Cancer

NCT05355727 is registered in ClinicalTrials.gov with Guy's and St Thomas' NHS Foundation Trust as lead sponsor.

NCT NCT05355727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05355727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROSAIC-DS (PROState AI in Cancer - Decision Support): Evaluation of the Deontics AI Platform for Evidence-based Treatment Planning in Multidisciplinary Cancer Care: Increasing Compliance and Streamlining MDTs in Prostate Cancer
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2022
Completion date
December 31, 2022
Enrollment
1,040 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer